Torrent Pharmaceuticals Limited (TORNTPHARM.NS)
INR 3129.0
(0.07%)
INR 3129.0
(0.07%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 21.42 Billion INR | -41.45% |
| 2022 | 45.94 Billion INR | 11.72% |
| 2021 | 41.11 Billion INR | 7.57% |
| 2020 | 38.22 Billion INR | -4.64% |
| 2019 | 40.08 Billion INR | 6.29% |
| 2018 | 37.71 Billion INR | 20.12% |
| 2017 | 31.39 Billion INR | 16.3% |
| 2016 | 26.99 Billion INR | 14.32% |
| 2015 | 23.61 Billion INR | 3.82% |
| 2014 | 22.74 Billion INR | 27.85% |
| 2013 | 17.79 Billion INR | 22.36% |
| 2012 | 14.54 Billion INR | 24.79% |
| 2011 | 11.65 Billion INR | 8.84% |
| 2010 | 10.7 Billion INR | 9.11% |
| 2009 | 9.81 Billion INR | 12.09% |
| 2008 | 8.75 Billion INR | 1.12% |
| 2007 | 8.65 Billion INR | 20.24% |
| 2006 | 7.2 Billion INR | 38.66% |
| 2005 | 5.19 Billion INR | 73.71% |
| 2004 | 2.98 Billion INR | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 7.11 Billion INR | 2.01% |
| 2024 Q2 | 14.12 Billion INR | 2.53% |
| 2023 Q4 | 6.97 Billion INR | -47.91% |
| 2023 FY | 26.9 Billion INR | -41.45% |
| 2023 Q2 | 13.44 Billion INR | 3.54% |
| 2023 Q3 | 13.38 Billion INR | -0.45% |
| 2023 Q1 | 12.98 Billion INR | 6.66% |
| 2022 Q4 | 12.17 Billion INR | 1.59% |
| 2022 Q2 | 11.04 Billion INR | 2.7% |
| 2022 FY | 45.94 Billion INR | 11.72% |
| 2022 Q1 | 10.75 Billion INR | 8.26% |
| 2022 Q3 | 11.98 Billion INR | 8.51% |
| 2021 FY | 41.11 Billion INR | 7.57% |
| 2021 Q4 | 9.92 Billion INR | -8.31% |
| 2021 Q2 | 10.16 Billion INR | -0.39% |
| 2021 Q3 | 10.83 Billion INR | 6.59% |
| 2021 Q1 | 10.2 Billion INR | 11.77% |
| 2020 Q1 | 9.79 Billion INR | 6.92% |
| 2020 FY | 38.22 Billion INR | -4.64% |
| 2020 Q2 | 9.61 Billion INR | -1.84% |
| 2020 Q3 | 9.7 Billion INR | 0.94% |
| 2020 Q4 | 9.12 Billion INR | -5.92% |
| 2019 Q1 | 10.36 Billion INR | 19.01% |
| 2019 Q2 | 10.52 Billion INR | 1.54% |
| 2019 Q3 | 10.05 Billion INR | -4.47% |
| 2019 Q4 | 9.15 Billion INR | -8.89% |
| 2019 FY | 40.08 Billion INR | 6.29% |
| 2018 Q1 | 9.49 Billion INR | -1.35% |
| 2018 Q3 | 9.63 Billion INR | -2.63% |
| 2018 FY | 37.71 Billion INR | 20.12% |
| 2018 Q2 | 9.89 Billion INR | 4.21% |
| 2018 Q4 | 8.7 Billion INR | -9.61% |
| 2017 Q2 | 7.38 Billion INR | 1.1% |
| 2017 Q4 | 9.62 Billion INR | 21.62% |
| 2017 Q3 | 7.91 Billion INR | 7.18% |
| 2017 FY | 31.39 Billion INR | 16.3% |
| 2017 Q1 | 7.3 Billion INR | 5.34% |
| 2016 Q1 | 6.75 Billion INR | 5.14% |
| 2016 FY | 26.99 Billion INR | 14.32% |
| 2016 Q4 | 6.93 Billion INR | 5.64% |
| 2016 Q3 | 6.56 Billion INR | -6.42% |
| 2016 Q2 | 7.01 Billion INR | 3.85% |
| 2015 Q4 | 6.42 Billion INR | 18.89% |
| 2015 FY | 23.61 Billion INR | 3.82% |
| 2015 Q1 | 5.51 Billion INR | -30.33% |
| 2015 Q2 | 5.52 Billion INR | 0.18% |
| 2015 Q3 | 5.4 Billion INR | -2.17% |
| 2014 Q4 | 7.9 Billion INR | 48.37% |
| 2014 FY | 22.74 Billion INR | 27.85% |
| 2014 Q2 | 5.33 Billion INR | 27.51% |
| 2014 Q1 | 4.18 Billion INR | -4.85% |
| 2014 Q3 | 5.33 Billion INR | 0.0% |
| 2013 Q4 | 4.39 Billion INR | -6.13% |
| 2013 Q1 | 4.04 Billion INR | 21.23% |
| 2013 FY | 17.79 Billion INR | 22.36% |
| 2013 Q2 | 4.68 Billion INR | 15.84% |
| 2013 Q3 | 4.68 Billion INR | 0.0% |
| 2012 Q1 | 3.66 Billion INR | 44.69% |
| 2012 Q2 | 3.84 Billion INR | 4.92% |
| 2012 Q3 | 3.72 Billion INR | -3.05% |
| 2012 Q4 | 3.33 Billion INR | -10.48% |
| 2012 FY | 14.54 Billion INR | 24.79% |
| 2011 FY | 11.65 Billion INR | 8.84% |
| 2011 Q3 | 3.36 Billion INR | 0.0% |
| 2011 Q4 | 2.52 Billion INR | -24.92% |
| 2010 FY | 10.7 Billion INR | 9.11% |
| 2009 FY | 9.81 Billion INR | 12.09% |
| 2008 FY | 8.75 Billion INR | 1.12% |
| 2007 FY | 8.65 Billion INR | 20.24% |
| 2006 FY | 7.2 Billion INR | 38.66% |
| 2005 FY | 5.19 Billion INR | 73.71% |
| 2004 FY | 2.98 Billion INR | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 15.86 Billion INR | -34.987% |
| Hester Biosciences Limited | 908.84 Million INR | -2257.082% |
| Aarti Drugs Limited | 1.16 Billion INR | -1734.902% |
| Aarti Pharmalabs Limited | 3.07 Billion INR | -596.79% |
| Albert David Limited | 1.02 Billion INR | -1987.625% |
| Alembic Limited | 872.45 Million INR | -2355.373% |
| Alkem Laboratories Limited | 32.83 Billion INR | 34.758% |
| Bafna Pharmaceuticals Limited | 455.58 Million INR | -4602.108% |
| Bajaj HealthCare Limited | 985.34 Million INR | -2074.071% |
| Biofil Chemicals and Pharmaceuticals Limited | 6.82 Million INR | -314007.038% |
| Brooks Laboratories Limited | 51.18 Million INR | -41756.389% |
| Eris Lifesciences Limited | 4.94 Billion INR | -333.388% |
| FDC Limited | 3.49 Billion INR | -512.102% |
| Glenmark Life Sciences Limited | 11.64 Billion INR | -84.028% |
| Gufic Biosciences Limited | 1.18 Billion INR | -1705.351% |
| Hikal Limited | 4.46 Billion INR | -379.907% |
| Ind-Swift Limited | 946.56 Million INR | -2163.136% |
| Innova Captab Limited | 931.03 Million INR | -2200.903% |
| IOL Chemicals and Pharmaceuticals Limited | 2.2 Billion INR | -873.289% |
| Jagsonpal Pharmaceuticals Limited | 438.55 Million INR | -4784.757% |
| Jubilant Pharmova Limited | 14.45 Billion INR | -48.209% |
| Lincoln Pharmaceuticals Limited | 1.07 Billion INR | -1894.264% |
| Lupin Limited | 125.09 Billion INR | 82.875% |
| Mangalam Drugs & Organics Limited | 162.22 Million INR | -13104.934% |
| Medico Remedies Limited | 59.67 Million INR | -35797.947% |
| Morepen Laboratories Limited | 1.98 Billion INR | -977.869% |
| Nectar Lifesciences Limited | 932.7 Million INR | -2196.784% |
| Orchid Pharma Limited | 800.77 Million INR | -2575.184% |
| Procter & Gamble Health Limited | 2.99 Billion INR | -615.167% |
| RPG Life Sciences Limited | 1.63 Billion INR | -1209.82% |
| Kilitch Drugs (India) Limited | 412.42 Million INR | -5094.156% |
| Sigachi Industries Limited | 579.88 Million INR | -3594.185% |
| Solara Active Pharma Sciences Limited | 2.55 Billion INR | -738.734% |
| Suven Pharmaceuticals Limited | 1.4 Billion INR | -1427.108% |
| Themis Medicare Limited | 1.12 Billion INR | -1802.837% |
| Unichem Laboratories Limited | 6.72 Billion INR | -218.503% |
| Vaishali Pharma Limited | 84.02 Million INR | -25393.699% |
| Wanbury Limited | 978.96 Million INR | -2088.237% |
| Windlas Biotech Limited | 1 Billion INR | -2028.354% |
| ZIM Laboratories Limited | 1.01 Billion INR | -2014.598% |
| Ind-Swift Laboratories Limited | 2.12 Billion INR | -908.486% |
| Ipca Laboratories Limited | 18.98 Billion INR | -12.822% |
| Sun Pharmaceutical Industries Limited | 154.18 Billion INR | 86.106% |
| Venus Remedies Limited | 1.91 Billion INR | -1017.898% |
| Sakar Healthcare Limited | 204.07 Million INR | -10396.964% |
| Aurobindo Pharma Limited | 55.65 Billion INR | 61.511% |
| Divi's Laboratories Limited | 14.17 Billion INR | -51.179% |
| AstraZeneca Pharma India Limited | 2.47 Billion INR | -766.064% |
| Mankind Pharma Limited | 29.27 Billion INR | 26.819% |
| Sequent Scientific Limited | 2.9 Billion INR | -638.232% |
| Laurus Labs Limited | 11.9 Billion INR | -79.87% |
| Neuland Laboratories Limited | 2.92 Billion INR | -631.193% |
| J. B. Chemicals & Pharmaceuticals Limited | 14.79 Billion INR | -44.817% |
| Glenmark Pharmaceuticals Limited | 46.95 Billion INR | 54.375% |
| Zydus Lifesciences Limited | 125.21 Billion INR | 82.891% |
| Amrutanjan Health Care Limited | 2.09 Billion INR | -923.005% |
| Wockhardt Limited | 8.48 Billion INR | -152.619% |
| Bal Pharma Limited | 555.62 Million INR | -3755.489% |
| Dr. Reddy's Laboratories Limited | 95.87 Billion INR | 77.657% |
| Bliss GVS Pharma Limited | 1.41 Billion INR | -1409.426% |
| Par Drugs and Chemicals Limited | 58.28 Million INR | -36652.15% |
| Caplin Point Laboratories Limited | 2.17 Billion INR | -885.151% |
| Shilpa Medicare Limited | 3.33 Billion INR | -542.5% |
| Valiant Laboratories Limited | 138.02 Million INR | -15419.999% |
| Ajanta Pharma Limited | 30.46 Billion INR | 29.678% |
| Aarey Drugs & Pharmaceuticals Limited | 14.21 Million INR | -150621.874% |
| Granules India Limited | 10.31 Billion INR | -107.723% |
| Medicamen Biotech Limited | 335.16 Million INR | -6291.471% |
| Syncom Formulations (India) Limited | 345.63 Million INR | -6097.932% |
| Piramal Enterprises Limited | 63.65 Billion INR | 66.345% |
| NATCO Pharma Limited | 10.05 Billion INR | -112.986% |
| Suven Life Sciences Limited | 109.75 Million INR | -19418.998% |
| Krebs Biochemicals & Industries Limited | 46.15 Million INR | -46312.384% |
| Strides Pharma Science Limited | 9.16 Billion INR | -133.807% |
| Indoco Remedies Limited | 12.06 Billion INR | -77.612% |
| Alpa Laboratories Limited | 127.38 Million INR | -16717.475% |
| Lasa Supergenerics Limited | 291.17 Million INR | -7257.147% |
| Sun Pharma Advanced Research Company Limited | 3.07 Billion INR | -596.246% |